Evolving Role of BTK Inhibitors in CLL: Experts Answer Your Questions
CCO Oncology Podcast - Podcast tekijän mukaan Clinical Care Options
Kategoriat:
In this podcast episode, listen to Farrukh T. Awan, MD, and Nicole Lamanna, MD, answer questions from an audience of healthcare professionals on the evolving role of BTK inhibitors in CLL, including sequencing, combinations, and novel agents.
